P392-2337 Screening compound: N-ethyl-2-{[1-(4-phenylbutanoyl)pyrrolidin-3-yl]oxy}pyridine-3-carboxamide

P392-2337 Screening compound: N-ethyl-2-{[1-(4-phenylbutanoyl)pyrrolidin-3-yl]oxy}pyridine-3-carboxamide
P392-2337 Screening compound: N-ethyl-2-{[1-(4-phenylbutanoyl)pyrrolidin-3-yl]oxy}pyridine-3-carboxamide alternative view

Chemical Structure Depiction of ChemDiv screening compound P392-2337
N-ethyl-2-{[1-(4-phenylbutanoyl)pyrrolidin-3-yl]oxy}pyridine-3-carboxamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

P392-2337

Molecular Formula

C22H27N3O3 (C22 H27 N3 O3)

Compound Name

N-ethyl-2-{[1-(4-phenylbutanoyl)pyrrolidin-3-yl]oxy}pyridine-3-carboxamide

IUPAC name

N-ethyl-2-{[1-(4-phenylbutanoyl)pyrrolidin-3-yl]oxy}pyridine-3-carboxamide

SMILES

CCNC(c(cccn1)c1OC(CC1)CN1C(CCCc1ccccc1)=O)=O

MDL Number (MFCD)

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

381.47

Hydrogen Bond Acceptors Count

6.00

Hydrogen Bond Donors Count

1.00

Rotatable Bond Count

10.00

Number of Nitrogen and Oxygen Atoms

6

Partition Coefficient, logP

2.974

Distribution Coefficient, logD

2.974

Water Solubility, LogSw

-3.45

Polar Surface Area

57.036

Acid Dissociation Constant (pKa)

12.19

Base Dissociation Constant (pKb)

-0.13

Number of Chiral Centers

1.00

Percent sp3 carbon bonding

40.90

P392-2337 in Drug Discovery

Included in Screening Libraries

Ligand-Gated Ion Channels Library (3887 compounds)

PI3K-Targeted Library (17255 compounds)

Protein-Protein Interaction Library (218420 compounds)

Beyond the Flatland Library sp3 enriched (92988 compounds)

MEF2-HDAC (class II) Modulators Library (5147 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Nervous system
  • Eye
  • Cancer
  • Digestive system
  • Respiratory tract
  • Otorhinolaryngologic
  • Male
  • Female
  • Hemic and lymphatic
  • Skin
  • Cancer
  • Musculoskeletal
  • Female
  • Hemic and lymphatic
  • Cardiovascular
Targets:
  • Ion Channels
  • Kinases
Mechanism of action:
  • PPI modulators
  • PPI modulators
  • Epigenetic
Structure:
  • Cyclic compounds

References: we are preparing a list of scientific research reports with P392-2337 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound P392-2337?
Check Price and Availability of P392-2337, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of P392-2337 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for P392-2337
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for P392-2337
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of P392-2337 available by request